학술논문

Scaling analysis reveals the mechanism and rates of prion replication in vivo
Document Type
article
Source
Nature Structural & Molecular Biology. 28(4)
Subject
Biochemistry and Cell Biology
Biological Sciences
Brain Disorders
Neurosciences
Rare Diseases
Infectious Diseases
Acquired Cognitive Impairment
Dementia
Emerging Infectious Diseases
Neurodegenerative
Transmissible Spongiform Encephalopathy (TSE)
Aging
Aetiology
2.1 Biological and endogenous factors
Neurological
Alzheimer Disease
Amyloid
Animals
Humans
Mice
Models
Theoretical
Parkinson Disease
Prions
Protein Aggregation
Pathological
Chemical Sciences
Medical and Health Sciences
Biophysics
Developmental Biology
Biological sciences
Biomedical and clinical sciences
Chemical sciences
Language
Abstract
Prions consist of pathological aggregates of cellular prion protein and have the ability to replicate, causing neurodegenerative diseases, a phenomenon mirrored in many other diseases connected to protein aggregation, including Alzheimer's and Parkinson's diseases. However, despite their key importance in disease, the individual processes governing this formation of pathogenic aggregates, as well as their rates, have remained challenging to elucidate in vivo. Here we bring together a mathematical framework with kinetics of the accumulation of prions in mice and microfluidic measurements of aggregate size to dissect the overall aggregation reaction into its constituent processes and quantify the reaction rates in mice. Taken together, the data show that multiplication of prions in vivo is slower than in in vitro experiments, but efficient when compared with other amyloid systems, and displays scaling behavior characteristic of aggregate fragmentation. These results provide a framework for the determination of the mechanisms of disease-associated aggregation processes within living organisms.